All
Genetic Predisposition Affects Treatment, Surveillance of Children with Medulloblastoma
June 18th 2018Researchers identified six gene variations that play an important role in the treatment and surveillance of children with medulloblastoma, for which they developed screening and counseling recommendations.
Testing Only the 'Tip of the Iceberg' for Common Hereditary Condition in MSI-H Tumors
June 14th 2018Lynch syndrome – a hereditary condition that increases a person’s risk for developing several types of cancer – is common among people with microsatellite instability-high (MSI-H) tumors, linking it to several new cancer types, according to large genomic study results presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.
Frontline Keytruda Effective in NSCLC Subgroup, But More Work Is Needed
June 13th 2018In the Keynote-042 trial, researchers found a four- to eight-month overall survival benefit among patients with non-small cell lung cancer (NSCLC), which was correlated with higher levels of PD-L1 expression, however, further study is warranted.
FDA Approves Keytruda for Relapsed/Refractory PMBCL
June 13th 2018The FDA has granted an accelerated approval to Keytruda (pembrolizumab) for the treatment of adult and pediatric patients with refractory primary mediastinal large B-cell lymphoma (PMBCL), or those who have relapsed after 2 or more prior lines of therapy.
FDA Approves Avastin Regimen for Ovarian Cancer Treatment
June 13th 2018The Food and Drug Administration approved a combination of Avastin (bevacizumab) plus the chemotherapy agents carboplatin and paclitaxel, followed by Avastin alone, for the treatment of patients with advanced ovarian cancer who have had surgical resection.
Nudes and Breast Cancer: Personal Documentary and Art
June 13th 2018Sometimes breast cancer invites us to look closely at our own bodies the way we might look at famous nudes. Creating visual art can be therapeutic, whether it involves photography or digital. Watercolors, sketches and collages could be empowering, too.
Survey Sheds Light on Why Some Use Cannabis After Stem Cell Transplant
June 13th 2018Nearly 20 percent of hematopoietic stem cell transplant (HSCT) survivors reported using cannabis, not just to ease physical and emotional side effects, but in the hopes that it would help treat their cancer, according to patient survey results presented at the 2018 of American Society of Clinical Oncology (ASCO) Annual Meeting.
FDA Grants Priority Review to GARDASIL 9 for Expanded Age Indication
June 13th 2018The application is seeking approval for GARDASIL 9 to be used in women and men aged 27 to 45 years for the prevention of certain cancers and diseases caused by the nine human papillomavirus (HPV) types covered by the vaccine.
FDA Approves Addition of Survival Data to Kyprolis Label for Multiple Myeloma Treatment
June 12th 2018The Food and Drug Administration (FDA) approved the supplemental New Drug Application to add to the U.S. Prescribing Information for Kyprolis (carfilzomib) for the treatment of patients with relapsed or refractory multiple myeloma.